Table 2.
Gene | dbSNP ID [12] or [Ref] | DNA, Genome Sequence | KD, nM | Clinical Data or Candidate SNP Markers | AS | Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5′ flank | WT | min | 3′ flank | WT | min | Δ | Z | α | ρ | |||||
CETP | rs1427119663 | cgtgggggct | 18bp | - | gggctccagg | 4 | 7 | < | 7 | 10−6 | A | hyperalpha-lipoprotei-nemia (athero-protector) | ↓ | [58] |
rs1002690375 | gggccactta | c | t | acaccactgc | 4 | 2 | > | 11 | 10−6 | A | accelerated atherogenesis, which can be slowed down by swimming | ↑ | [61,62] | |
rs757176551 | catatacggg | c | g | tccaggctga | 4 | 2 | > | 10 | 10−6 | A | ↑ | |||
rs569033466 | atacatatac | g | a, t, c | ggctccaggc | 4 | 3 | > | 4 | 10−3 | B | ↑ | |||
rs1451694749 | catacatata | c | t | gggctccagg | 4 | 2 | > | 12 | 10−6 | A | ↑ | |||
MBL2 | rs72661131 | tctatttcta | t | c | tatagcctgc | 2 | 4 | < | 12 | 10−6 | A | stroke, pre-eclampsia, variable immune-deficiency | ↑ | [64,65,66] |
rs1471733364 | tatttctata | t | g | agcctgcacc | 2 | 5 | < | 15 | 10−6 | A | on the Western diet, MBL2 deficit and excess quicken earlier and late atherogenesis, respectively | ↑ | [67,68,69] | |
rs562962093 | atctatttct | a | g | tatagcctgc | 2 | 5 | < | 15 | 10−6 | A | ↑ | |||
rs567653539 | tttctatata | g | a | cctgcaccca | 2 | 1 | > | 4 | 10−3 | B | ↑ | |||
F3 | rs563763767 | ccctttatag | c | t * | gcgcggggca | 3 | 2 | > | 6 | 10−6 | A | myocardial infarction, thrombosis | ↑ | [70] |
rs1439518731 | gccctttata | - | ta | gcgcgcgggg | 3 | 1 | > | 12 | 10−6 | A | accelerated atherogenesis that can be slowed down by aspirin slowed down atherogenesis | ↑ | [71,72] | |
rs966076891:t | gccgccggcc | c | t | tttatagcgc | 3 | 2 | > | 6 | 10−6 | A | ↑ | |||
rs966076891:g | gccgccggcc | c | g | tttatagcgc | 3 | 4 | < | 2 | 0.05 | D | ↓ | [73] | ||
rs1190659847 | gccggccctt | t | c | atagcgcgcg | 3 | 12 | < | 19 | 10−6 | A | ↓ | |||
TPI1 | rs1800202 | gcgctctata | t | g | aagtgggcag | 1 | 4 | < | 17 | 10−6 | A | hemolytic anemia, neu-romuscular diseases | ↑ | [74,75] |
rs1386262216 | gcggcgctct | a | c, g | tataagtggg | 1 | 2 | < | 8 | 10−6 | A | traumatic and ischemic co-mplications of atherogenesis | ↑ | [76,77] | |
rs781835924 | cgcggcgctc | t | c | atataagtgg | 1 | 2 | < | 10 | 10−6 | A | ↑ |
Notes. Hereinafter, Alleles: wt, ancestral; min, minor; “-”, deletion. KD, dissociation constant of the TBP–DNA complex; α = 1 – p, significance (where p value is given in Figure 1); Gene expression changes (Δ): an increase (>) and decrease (<); Atherogenesis (AS): accelerated (↑) and slowed down (↓); ρ, heuristic rank of candidate SNP markers from the “best” (A) to the “worst” (E). * This SNP also includes other neutral alleles. Diseases: RA, rheumatoid arthritis. Genes: CETP, cholesteryl ester transfer protein; MBL2, mannose-binding lectin 2 (synonyms: collectin-1); F3, coagulation factor III (synonyms: thromboplastin, tissue factor); TPI1, triosephosphate isomerase 1. Deletions, CETP: 18bp = gggcggacatacatatac.